ABTECo — Aqua Bio Technology ASA Cashflow Statement
0.000.00%
- NOK12.10m
- NOK118.22m
- NOK1.34m
Annual cashflow statement for Aqua Bio Technology ASA, fiscal year end - December 31st, NOK millions except per share, conversion factor applied.
C2021 December 31st | 2022 December 31st | 2023 December 31st | R2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -19.1 | -18.8 | -20.8 | -121 | -24.6 |
| Depreciation | |||||
| Non-Cash Items | 1.8 | 1.58 | 8.04 | -163 | 7.87 |
| Discontinued Operations | |||||
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -4.74 | 0.051 | -10.2 | 52.9 | 1.92 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -21 | -15.4 | -19.3 | -56.2 | -8.15 |
| Capital Expenditures | -3.87 | 0 | -1.41 | -1.07 | — |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -1.54 | -4.09 | 0.006 | 1.51 | 0.5 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -5.41 | -4.09 | -1.4 | 0.447 | 0.5 |
| Financing Cash Flow Items | -0.001 | -0.044 | -0.431 | -2.64 | -1.66 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 34.3 | 8.04 | 23.7 | 56.9 | 4.31 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 7.93 | -11.5 | 2.98 | 1.16 | -3.34 |